Pledge to make a difference, together.
cc-TDI runs preclinical and translational research to identify disease-specific treatments for childhood cancers and advance promising therapies into clinical trials. The institute focuses on rare and high‑risk pediatric tumors and shares data/resources to accelerate drug development so more childhood cancers become survivable.